Dr. David Robert Rawnsley, MD

Dr. Rawnsley practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Rawnsley's NPI, 1457732745, was assigned on June 12, 2015. Dr. Rawnsley graduated from Perelman School of Med at the University of Pennsylvania in 2015. Dr. Rawnsley holds Missouri license 2021040304.

Dr. Rawnsley's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Rawnsley also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Rawnsley's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Rawnsley is also affiliated with Barnes-Jewish West County Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Rawnsley to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rawnsley practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rawnsley's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rawnsley is licensed in Missouri.

CMS data shows 336 Medicare services from Dr. Rawnsley across 12 procedure codes in 2024, for 169 Medicare patients. Medicare paid $13,198 for them.

CMS counts 169 Medicare patients who saw Dr. Rawnsley in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rawnsley's median patient age at 70, with 50% women.

In 2017, Dr. Rawnsley wrote 536 Medicare Part D claims. They cover 20 drugs, with $20,903 in total drug cost. In 2016, CMS named 210 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Rawnsley for performance year 2024, reported as part of a group. Dr. Rawnsley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Rawnsley, published from 2016 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Lysosomes. Dr. Rawnsley has published most often in JACC Basic Transl Sci. Dr. Rawnsley's most frequent co-authors are Abhinav Diwan, MD, Attila Kovacs, MD and Ali Javaheri, MD.

Dr. Rawnsley graduated from Perelman School of Med at the University of Pennsylvania in 2015.